Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.14

-1.7%

2:38 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (8745)	6/23/2003 10:29:43 AM
From: scaram(o)uche	Read Replies (1) of 52153

>> Is this a case of an extremely incompetent R&D management or a realistic appreciation of the problems of developing biotech based drugs? << Amevive.... very few foresaw that anti-TNF would be so effective. I didn't, and my background is square-on and I've followed the projects closely. R&D brought forward the first biological approved for psoriasis. They have expertise with B cell biology that is perhaps unsurpassed by any group other than Idec's. ;-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next